Advertisement

Topics

Topas Therapeutics inks research agreement with Eli Lilly on immune tolerance

08:16 EDT 23 Aug 2017 | PharmaBiz

Topas Therapeutics GmbH, a Hamburg, Germany─based private company, has announced that it has signed a multi─year agreement with Eli Lilly and Company (Lilly) to collaborate in the field of antigen─specific tolerance

Original Article: Topas Therapeutics inks research agreement with Eli Lilly on immune tolerance

NEXT ARTICLE

More From BioPortfolio on "Topas Therapeutics inks research agreement with Eli Lilly on immune tolerance"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...